Skip to main content

Table 1 Parameters and their default values for the model

From: LncRNA HOTAIR-mediated Wnt/β-catenin network modeling to predict and validate therapeutic targets for cartilage damage

Parameter

Process

Default Value

Reference

k1

Synthesis of HOTAIR

0.2 nM•min− 1

[23, 28]

k2

Degradation of HOTAIR

0.1 min− 1

[23, 28]

V3

Inhibition of WIF-1 synthesis

1 nM•min− 1

[23, 28]

k+ 4

Inhibition of Wnt synthesis

1 nM− 1•min− 1

[23, 28]

k− 4

Dissociation of WIF-1 from the [WIF-1.Wnt] complex

1 min− 1

[20]

k+ 5

Binding of LRP5/6 to Fzl to form [LRP5/6.Fzl]

0.1 nM− 1•min− 1

[30,31,32]

k− 5

Dissociation of [LRP5/6] into LRP5/6 and Fzl

1 min− 1

[30,31,32]

k+ 6

Binding of Wnt to [LRP5/6.Fzl] to form [Wnt.LRP5/6.Fzl]

1 nM− 1•min− 1

[30,31,32]

k−6

Dissociation of [Wnt.LRP5/6.Fzl] into Wnt and [LRP5/6. Fzl]

1 min− 1

[30,31,32]

k+ 7

Binding of LRP5/6 to Axin to form [LRP5/6.Axin]

1 nM− 1•min− 1

[30,31,32]

k−7

Dissociation of [LRP5/6.Axin] into LRP5/6 and Axin

1 min− 1

[30,31,32]

k8

Activation of Dsh

0.182 min− 1

[30,31,32]

k9

Deactivation of Dsh

0.0182 min− 1

[30,31,32]

k10

Dissociation of GSK3 from the destruction complex

0.05 nM− 1•min− 1

[30,31,32]

k+ 11

Binding of GSK3 to [Axin.APC] to form [GSK3. APC.Axin]

0.0909 nM− 1•min− 1

[30,31,32]

k− 11

Dissociation of [GSK3.APC.Axin] into GSK3 and [Axin.APC]

100 min− 1

[30,31,32]

k+ 12

Phosphorylation of Axin and APC

0.267 min− 1

[30,31,32]

k− 12

Dephosphorylation of Axin and APC

1 min− 1

[30,31,32]

k+ 13

Binding of APC to Axin to form [APC.Axin]

1 nM− 1•min− 1

[30,31,32]

k− 13

Dissociation of [APC.Axin] into APC and Axin

100 min− 1

[30,31,32]

k+ 14

Binding of β-catenin to [GSK3.APC*.Axin*] to form [GSK3.APC*.Axin*.β-catenin]

120 nM− 1•min− 1

[30,31,32]

k− 14

Dissociation of [GSK3.APC*.Axin*.β-catenin] into β-catenin and [GSK3.APC*.Axin*]

1 min− 1

[30,31,32]

k15

Phosphorylation of β-catenin

206 min− 1

[30,31,32]

k16

Dissociation of phosphorylated β-catenin

0.5 min− 1

[30,31,32]

k17

Degradation of phosphorylated β-catenin

0.417 min− 1

[30,31,32]

k18

Synthesis of Axin

8.22*10− 5 nM•min− 1

[30,31,32]

k19

Degradation of Axin

0.167 min− 1

[30,31,32]

k+ 20

Binding of APC to β-catenin to form [APC.β-catenin]

1 nM− 1•min− 1

[30,31,32]

k− 20

Dissociation of [APC.β-catenin] into APC and β-catenin

120 min− 1

[30,31,32]

k21

Synthesis of β-catenin

0.423 nM•min− 1

[30,31,32]

k22

Degradation of β-catenin

0.000257 min− 1

[30,31,32]

k+ 23

Binding of TCF to β-catenin to form [TCF.β-catenin]

2 nM− 1•min− 1

[30,31,32]

k− 23

Dissociation of [TCF.β-catenin] into TCF and β-catenin

20 min− 1

[30,31,32]

k24

Synthesis of Axin induced by [TCF.β-catenin]

0.02 min− 1

[30,31,32]

k25

Synthesis of MMP-13

0.1 nM•min− 1

[21]

k26

Degradation of MMP-13

0.1 min− 1

[21]

V27

Activation of MMP-13 synthesis

0.1 nM•min− 1

[21]

K3

Inhibition constant of WIF-1 by HOTAIR

0.1 nM

[23, 28]

K8

Activation constant of Dsh by Wnt

10 nM

[30, 31]

K27

Activation constant of MMP-13 by [TCF.β-catenin]

1 nM

[21]

m3

Degree of cooperativity of repression of WIF-1 expression by HOTAIR

4

[23, 28]

m27

Degree of cooperativity of activation of MMP-13 expression by [TCF.β-catenin]

4

[23, 28]

Wnt

Initial concentration of Wnt

10 nM

[30, 31, 33]

Fzl

Initial concentration of Fzl

10 nM

[30, 31, 33]

WIF-1

Initial concentration of WIF-1

10 nM

[30, 31, 33]

Dsh

Initial concentration of Dsh

100 nM

[30, 31, 33]

APC

Initial concentration of APC

100 nM

[30, 31, 33]

TCF

Initial concentration of TCF

15 nM

[30, 31, 33]

GSK3

Initial concentration of GSK3

50 nM

[30, 31, 33]